Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 765179 |
Trade Name | |
Synonyms | BI765179|BI-765179 |
Drug Descriptions |
BI 765179 is a bispecific antibody that targets TNFRSF9 (CD137; 4-1BB) expressed on immune cells and fibroblast activation protein (FAP) expressed on cancer-associated fibroblasts, which potentially results in activation of immune cells and a T-lymphocyte mediated immune response against tumor cells (NCI Drug Dictionary). |
DrugClasses | TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | C190717 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI 765179 | BI 765179 | 0 | 1 |
BI 765179 + Ezabenlimab | BI 765179 Ezabenlimab | 0 | 1 |